-
Je něco špatně v tomto záznamu ?
Pancreatic islet autotransplantation after completion pancreatectomy for pancreatic fistula after hemipancreatoduodenectomy for carcinoma
M. Kocik, K. Lipar, F. Saudek, P. Girman, P. Boucek, M. Kucera, J. Fronek, M. Oliverius,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- autologní transplantace MeSH
- diabetes mellitus 1. typu etiologie mortalita chirurgie MeSH
- karcinom mortalita patologie chirurgie MeSH
- kohortové studie MeSH
- lidé MeSH
- nádory slinivky břišní mortalita patologie chirurgie MeSH
- pankreatektomie škodlivé účinky MeSH
- pankreatická píštěl etiologie mortalita chirurgie MeSH
- pankreatoduodenektomie škodlivé účinky MeSH
- transplantace Langerhansových ostrůvků * MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: Pancreatic islet autotransplantation (IAT) has a potential to prevent brittle diabetes in patients after total pancreatectomy. Because of the fear of tumor spread, IAT has rarely been used in case of malignancy. We report our experience with patients who underwent hemipancreatoduodenectomy for carcinoma and later completion pancreatectomy for pancreatic fistula with islet autotransplantation at our institution. METHODS: From August 2007 to December 2012, 5 patients underwent IAT after completion pancreatectomy for pancreatic fistula after hemipancreatoduodenectomy for carcinoma. Islets were isolated from the pancreatic tail with the use of digestion with collagenase. Nonpurified islet suspension was infused into the portal vein during surgery. RESULTS: The median number of islets transplanted was 175,000 islet equivalents (range, 70,000-365,000). One patient died after surgery for reasons unrelated to IAT. Another 3 patients had stable diabetes with partial graft function (fasting C-peptide levels 0.23, 0.41, and 0.61 nmol/L and HbA1c 4.8%, 4.6%, and 6.9% at 24, 24 and 9 months after IAT, respectively). The 1st patient, with pancreatic head carcinoma, was alive 28 months after IAT with lymph node and liver recurrence since 18 months after IAT. The 2nd patient, with gall bladder and distal bile duct carcinoma, died 47 months after IAT with tumor recurrence. The 3rd patient, with ampullary carcinoma, died 12 months after IAT with local recurrence and solitary liver metastasis. The last patient had been off insulin 9 months after IAT without tumor recurrence (fasting C-peptide, 0.89 nmol/L; HbA1c, 4.2%). CONCLUSIONS: Autotransplantation of pancreatic islets isolated from the residual pancreatic tissue in patients who previously underwent hemipancreatoduodenectomy for cancer may provide stable glucose control and thus improve quality of life. In this small series we did not observe early development of multiple liver metastases caused by islet suspension contamination with malignant cells. Oncologic outcome of the patients was not worse than what would be expected without IAT.
Department of Diabetes Institute for Clinical and Experimental Medicine Prague Czech Republic
Transplant Surgery Department Institute for Clinical and Experimental Medicine Prague Czech Republic
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031901
- 003
- CZ-PrNML
- 005
- 20151014131550.0
- 007
- ta
- 008
- 151005s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.transproceed.2014.06.009 $2 doi
- 035 __
- $a (PubMed)25131092
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kocik, M $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: matej.kocik@ikem.cz.
- 245 10
- $a Pancreatic islet autotransplantation after completion pancreatectomy for pancreatic fistula after hemipancreatoduodenectomy for carcinoma / $c M. Kocik, K. Lipar, F. Saudek, P. Girman, P. Boucek, M. Kucera, J. Fronek, M. Oliverius,
- 520 9_
- $a OBJECTIVE: Pancreatic islet autotransplantation (IAT) has a potential to prevent brittle diabetes in patients after total pancreatectomy. Because of the fear of tumor spread, IAT has rarely been used in case of malignancy. We report our experience with patients who underwent hemipancreatoduodenectomy for carcinoma and later completion pancreatectomy for pancreatic fistula with islet autotransplantation at our institution. METHODS: From August 2007 to December 2012, 5 patients underwent IAT after completion pancreatectomy for pancreatic fistula after hemipancreatoduodenectomy for carcinoma. Islets were isolated from the pancreatic tail with the use of digestion with collagenase. Nonpurified islet suspension was infused into the portal vein during surgery. RESULTS: The median number of islets transplanted was 175,000 islet equivalents (range, 70,000-365,000). One patient died after surgery for reasons unrelated to IAT. Another 3 patients had stable diabetes with partial graft function (fasting C-peptide levels 0.23, 0.41, and 0.61 nmol/L and HbA1c 4.8%, 4.6%, and 6.9% at 24, 24 and 9 months after IAT, respectively). The 1st patient, with pancreatic head carcinoma, was alive 28 months after IAT with lymph node and liver recurrence since 18 months after IAT. The 2nd patient, with gall bladder and distal bile duct carcinoma, died 47 months after IAT with tumor recurrence. The 3rd patient, with ampullary carcinoma, died 12 months after IAT with local recurrence and solitary liver metastasis. The last patient had been off insulin 9 months after IAT without tumor recurrence (fasting C-peptide, 0.89 nmol/L; HbA1c, 4.2%). CONCLUSIONS: Autotransplantation of pancreatic islets isolated from the residual pancreatic tissue in patients who previously underwent hemipancreatoduodenectomy for cancer may provide stable glucose control and thus improve quality of life. In this small series we did not observe early development of multiple liver metastases caused by islet suspension contamination with malignant cells. Oncologic outcome of the patients was not worse than what would be expected without IAT.
- 650 _2
- $a karcinom $x mortalita $x patologie $x chirurgie $7 D002277
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a diabetes mellitus 1. typu $x etiologie $x mortalita $x chirurgie $7 D003922
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a transplantace Langerhansových ostrůvků $7 D016381
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pankreatektomie $x škodlivé účinky $7 D010180
- 650 _2
- $a pankreatická píštěl $x etiologie $x mortalita $x chirurgie $7 D010185
- 650 _2
- $a nádory slinivky břišní $x mortalita $x patologie $x chirurgie $7 D010190
- 650 _2
- $a pankreatoduodenektomie $x škodlivé účinky $7 D016577
- 650 _2
- $a autologní transplantace $7 D014182
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lipar, K $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Saudek, F $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Girman, P $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Boucek, P $u Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Kucera, M $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Fronek, J $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Oliverius, M $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 773 0_
- $w MED00004556 $t Transplantation proceedings $x 1873-2623 $g Roč. 46, č. 6 (2014), s. 1996-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25131092 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151014131740 $b ABA008
- 999 __
- $a ok $b bmc $g 1092777 $s 915027
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 46 $c 6 $d 1996-8 $i 1873-2623 $m Transplantation proceedings $n Transplant Proc $x MED00004556
- LZP __
- $a Pubmed-20151005